The bleeding with antithrombotic therapy study 2: Rationale, design, and baseline characteristics of the participants

AIMS: The bleeding risk of current antithrombotic strategies in clinical settings, including recently developed agents, needs to be clarified. METHODS AND DESIGN: In an investigator-initiated, prospective, multicentre, observational study, patients with cerebrovascular or cardiovascular diseases who...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur Stroke J
Autores principales: Takagi, Masahito, Tanaka, Kanta, Miwa, Kaori, Sasaki, Makoto, Koga, Masatoshi, Hirano, Teruyuki, Kamiyama, Kenji, Yagita, Yoshiki, Nagakane, Yoshinari, Hoshino, Haruhiko, Terasaki, Tadashi, Yakushiji, Yusuke, Kudo, Kohsuke, Ihara, Masafumi, Yoshimura, Sohei, Yamaguchi, Yoshitaka, Shiozawa, Masayuki, Toyoda, Kazunori
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2020
Materias:
Protocol
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7856591/
https://ncbi.nlm.nih.gov/pubmed/33598561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2396987320960618
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares